STOCK TITAN

Quince Financials

QNCX
FY2025 annual
Revenue Not reported for FY2025
Net Income -$84.0M -47.8% YoY
EPS (Diluted) -$1.68 YoY not available
Free Cash Flow -$41.8M -29.9% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

This page shows Quince (QNCX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI QNCX FY2025

Quince’s dominant mechanic is research-led cash consumption, with liquidity and balance-sheet support thinning as operating needs persist.

In FY2025, research and development spending rose to $35.4M from $18.6M in FY2024 while operating cash flow widened to -$41.4M, linking the larger research effort directly to heavier cash use. Free cash flow was -$41.8M, nearly matching operating cash flow, indicating that the shortfall is primarily operating investment rather than a large capital-spending program.

Liquidity has tightened sharply: cash was $5.8M against FY2025 operating cash flow of -$41.4M, leaving limited balance-sheet cushion relative to the reported annual spending pace. The current ratio fell to 0.5x from 6.1x in FY2024, meaning current assets no longer covered current obligations.

Positive investing and financing cash flows roughly offset the FY2025 operating outflow, so the period’s cash position was supported by non-operating sources rather than internally generated cash. Long-term debt fell from $14.3M in FY2024 to $0, yet liabilities reached $129.2M against assets of $93.5M; equity was consequently -$35.7M.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Quince does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
3/7

Quince passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass.

Earnings Quality No Cash Backing
N/A

Quince reported a net loss of $84.0M while operations used $41.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

EBITDA
-$57.9M
YoY-1.4%

Quince's EBITDA was -$57.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1.4% from the prior year.

Net Income
-$84.0M
YoY-47.8%

Quince reported -$84.0M in net income in fiscal year 2025. This represents a decrease of 47.8% from the prior year.

EPS (Diluted)
-$1.68

Quince earned -$1.68 per diluted share (EPS) in fiscal year 2025.

Revenue

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$41.8M
YoY-29.9%

Quince recorded an outflow of $41.8M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 29.9% from the prior year.

Cash & Debt
$5.8M
YoY-6.5%
5Y CAGR-38.7%

Quince held $5.8M in cash against $0 in long-term debt as of fiscal year 2025, with $43.2M of liabilities due within a year.

Shares Outstanding
278,627

Quince had 278,627 shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

None of these metrics is reported for fiscal year 2025.

Capital Allocation

R&D Spending
$35.4M
YoY+90.3%
5Y CAGR-10.4%

Quince invested $35.4M in research and development in fiscal year 2025. This represents an increase of 90.3% from the prior year.

Capital Expenditures
$352K
YoY+37.0%
5Y CAGR+46.6%

Quince invested $352K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 37.0% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

QNCX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

QNCX annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18
R&D ExpensesN/A$35.4M+90.3%$18.6M+96.8%$9.4M-62.5%$25.2M-58.6%$60.8M-0.8%$61.3M+102.9%$30.2M+199.6%$10.1M
SG&A ExpensesN/A$15.0M-14.4%$17.6M-0.6%$17.7M-32.0%$26.0M-11.9%$29.5M+67.9%$17.6M+96.4%$9.0M+340.2%$2.0M
Operating IncomeN/A-$58.1M-1.4%-$57.3M-65.5%-$34.6M+33.4%-$52.0M+42.4%-$90.3M-14.5%-$78.9M-101.4%-$39.2M-223.2%-$12.1M
Interest ExpenseN/AN/AN/AN/AN/AN/AN/AN/A$957K
Income TaxN/A$3.2M+3594.3%$87K+144.2%-$197K+30.6%-$284K$0$0$0$0
Net IncomeN/A-$84.0M-47.8%-$56.8M-81.0%-$31.4M+39.2%-$51.7M+42.6%-$89.9M-17.0%-$76.8M-107.8%-$37.0M-196.4%-$12.5M
EPS (Diluted)-$1.68-$1.31-56.0%-$0.84+45.5%-$1.54+49.2%-$3.03N/AN/AN/A

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

QNCX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

QNCX annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18
Total Assets$93.5M-18.3%$114.5M-31.8%$167.9M+61.6%$103.9M-22.0%$133.2M-29.7%$189.5M+52.3%$124.4M+70.7%$72.9M
Current Assets$22.9M-48.0%$44.0M-43.1%$77.4M-17.4%$93.7M-16.1%$111.7M-19.0%$137.9M+30.0%$106.1M+46.1%$72.6M
Cash & Equivalents$5.8M-6.5%$6.2M-70.1%$20.8M-48.9%$40.6M+37.8%$29.5M-55.9%$66.8M+30.5%$51.2M+105.9%$24.9M
GoodwillN/A$0-100.0%$17.6M$0$0N/AN/AN/A
Total Liabilities$129.2M+53.2%$84.3M+1.8%$82.8M+2396.7%$3.3M-77.3%$14.6M-14.9%$17.2M+93.5%$8.9M-91.6%$105.5M
Current Liabilities$43.2M+493.9%$7.3M-24.0%$9.6M+211.9%$3.1M-78.4%$14.2M-16.3%$17.0M+91.1%$8.9M+510.3%$1.5M
Long-Term Debt$0-100.0%$14.3M+6.6%$13.4M$0N/AN/AN/AN/A
Total Equity-$35.7M-218.5%$30.1M-64.6%$85.1M-15.4%$100.6M-15.2%$118.6M-31.2%$172.3M+49.2%$115.5M+453.9%-$32.6M
Retained Earnings-$460.5M-22.3%-$376.5M-17.8%-$319.6M-10.9%-$288.3M-21.8%-$236.6M-61.3%-$146.7M-110.1%-$69.8M-112.7%-$32.8M

Not reported in any period shown, so not listed: Inventory, Accounts Receivable.

QNCX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

QNCX annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18
Operating Cash Flow-$46.9M-$41.4M-29.8%-$31.9M-74.4%-$18.3M+58.5%-$44.0M+30.0%-$62.9M-23.8%-$50.8M-52.7%-$33.3M-184.5%-$11.7M
Capital Expenditures$78K$352K+37.0%$257K+60.6%$160K+20.3%$133K-26.1%$180K+246.2%$52K-5.5%$55K-74.1%$212K
Free Cash Flow-$47.0M-$41.8M-29.9%-$32.2M-74.3%-$18.5M+58.2%-$44.2M+30.0%-$63.1M-24.1%-$50.9M-52.6%-$33.3M-179.9%-$11.9M
Investing Cash Flow$26.3M$23.2M+6.0%$21.9M+480.5%-$5.8M-132.0%$18.0M-69.5%$59.0M+212.4%-$52.4M-195.4%-$17.7M+62.0%-$46.8M
Financing Cash Flow$121.8M$17.9M+475.1%-$4.8M-3439.2%$143K-79.8%$707K-89.6%$6.8M-94.3%$118.9M+53.7%$77.4M+1.9%$75.9M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

QNCX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

QNCX annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18
Return on EquityN/A-188.5%-151.6pp-36.9%+14.5pp-51.4%+24.5pp-75.8%-31.2pp-44.6%-12.6pp-32.0%N/A
Return on Assets-89.8%-40.2pp-49.6%-30.9pp-18.7%+31.0pp-49.7%+17.8pp-67.5%-27.0pp-40.6%-10.8pp-29.7%-12.6pp-17.1%
Current Ratio0.53-5.5x6.05-2.0x8.09-22.5x30.55+22.7x7.85-0.3x8.11-3.8x11.93-37.9x49.82
Debt-to-EquityN/A0.48+0.3x0.16+0.2x0.00-0.1x0.120.0x0.100.0x0.08N/A

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$35.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.53), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

Is Quince profitable?

No, Quince (QNCX) reported a net income of -$84.0M in fiscal year 2025.

What is Quince's earnings per share (EPS)?

Quince (QNCX) reported diluted earnings per share of -$1.68 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Quince's EBITDA?

Quince (QNCX) had EBITDA of -$57.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Quince (QNCX) had $5.8M in cash and equivalents against $0 in long-term debt.

Quince (QNCX) recorded an outflow of $41.8M in free cash flow during fiscal year 2025. This represents a -29.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Quince (QNCX) recorded an outflow of $41.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Quince (QNCX) had $93.5M in total assets as of fiscal year 2025, including both current and long-term assets.

Quince (QNCX) invested $352K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Quince (QNCX) invested $35.4M in research and development during fiscal year 2025.

Quince (QNCX) had 278,627 shares outstanding as of fiscal year 2025.

Quince (QNCX) had a current ratio of 0.53 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Quince (QNCX) had a return on assets of -89.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Quince (QNCX) had $5.8M in cash against an annual operating cash burn of $41.4M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Quince (QNCX) has negative shareholder equity of -$35.7M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Quince (QNCX) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Quince (QNCX) reported a net loss of $84.0M while operations used $41.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top